✦ LIBER ✦

The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections

✍ Scribed by Craig Winstanley; Joanne L. Fothergill

Book ID: 109331399
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 290
Category: Article
ISSN: 0378-1097
DOI: 10.1111/j.1574-6968.2008.01394.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of quorum sensing in the in viv

The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa

✍ Kendra P Rumbaugh; John A Griswold; Abdul N Hamood 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 645 KB

Mouse models of chronic lung infection w

Mouse models of chronic lung infection with Pseudomonas Aeruginosa: Models for the study of cystic fibrosis

✍ Peter K. Stotland; Danuta Radzioch; Mary M. Stevenson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Mucoid Pseudomonas aeruginosa and cystic

Mucoid Pseudomonas aeruginosa and cystic fibrosis: The role of mutations in muc loci

✍ John R.W. Govan; Daniel W. Martin; Vojo P. Deretic 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Role of the Pseudomonas aeruginosa las a

Role of the Pseudomonas aeruginosa las and rhl quorum-sensing systems in rhlI regulation

✍ Teresa R de Kievit; Yoshio Kakai; J.Kristen Register; Everett C Pesci; Barbara H 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

Epidemiology of Pseudomonas aeruginosa i

Epidemiology of Pseudomonas aeruginosa infection in cystic fibrosis and the use of strain genotyping

✍ D.L. Smith; E.G. Smith; L.B. Gumery; D.E. Stableforth; L.M. Dalla Costa; T.L. Pi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Changing Epidemiology of Pseudomonas aer

Changing Epidemiology of Pseudomonas aeruginosa Infection in Danish Cystic Fibrosis Patients (1974–1995)

✍ Birgitte Frederiksen; Christian Koch; Niels Høiby 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB

Recurrent and chronic lower airway infection with Pseudomonas aeruginosa (PA) is an important component of cystic fibrosis (CF) pulmonary disease. Different modes of treatment and control of CF patients have been introduced at the Copenhagen CF Centre over the past 20 years and have been associated